NDC 00054-0470-21
EVEROLIMUS 0.25MG 60 TABS
Available — 2-Day Shipping
NDC
00054-0470-21
Generic Name
—
Brand Name
—
Strength
—
Dosage Form
—
Route
—
Package Size
—
Labeler
—
FDA Drug Information
Indications & Usage
1. INDICATIONS AND USAGE Everolimus tablets are a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ( 1.1 ) Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that ar…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 00054-0470-21 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).